Discontinued — last reported Q3 '25
Roivant Sciences Gain (loss) on disposal of assets decreased by 83.2% to $21.59M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 201.3%, from -$21.31M to $21.59M. This is a positive signal — higher values indicate stronger performance for this metric.
A gain indicates successful capital recycling or asset appreciation, while a loss may suggest impairment or forced liquidation of assets.
This metric represents the net profit or loss realized from the divestiture of non-core business units, property, equipm...
Standard across all industries; peers often report this within 'Other Income' or 'Non-Operating Items'.
gain_loss_on_sale_of_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$8.62M | $32.27M | -$38.04M | -$72.91M | -$24.55M | -$54.68M | $25.95M | -$7.56M | -$45.85M | -$10.47M | $15.23M | $48.38M | -$21.31M | $12.90M | -$19.13M | $128.50M | $21.59M |
| QoQ Change | — | +474.4% | -217.9% | -91.7% | +66.3% | -122.7% | +147.5% | -129.2% | -506.1% | +77.2% | +245.5% | +217.7% | -144.1% | +160.5% | -248.3% | +771.9% | -83.2% |
| YoY Change | — | — | — | — | -184.8% | -269.4% | +168.2% | +69.2% | +16.1% | -140.3% | +301.3% | +205.5% | -103.6% | — | -225.6% | +165.6% | +201.3% |
| Segment | Q3 '25 | Q4 '25 |
|---|---|---|
| Reportable Segment | $128.50M | $21.59M |
| Total | $128.50M | $21.59M |